RECENT NEWS
HNL Lab Medicine announces groundbreaking digital pathology investment
HNL Lab Medicine, a leading multi-regional US-based clinical diagnostics laboratory, has made a groundbreaking investment in digital pathology, having selected solutions from Proscia, a digital pathology software company, and Leica Biosystems, a manufacturer of high-quality imaging hardware, to establish an advanced digital pathology practice.
Quest Diagnostics launches novel prostate cancer test
Quest Diagnostics has launched a novel prostate cancer biomarker test through its subspecialty pathology business, AmeriPath, in collaboration with Envision Sciences. The new, tissue-based test service is intended to address the pressing clinical need for tests to help identify and differentiate potentially aggressive cases of prostate cancer in men.
Thermo Fisher Scientific introduces new reproductive health assays
To extend the benefits of genomic testing research for reproductive health laboratories, Thermo Fisher Scientific has launched two new next-generation sequencing-based options to support preimplantation genetic testing-aneuploidy (PGT-A) used commonly to inform in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) research.
England on track to end new HIV transmissions thanks to increased testing
New HIV transmissions in England have fallen by almost a third since 2019, while fewer people remain unaware of their HIV status as a result of increased testing across the country, according to an update on the HIV Action Plan for England published recently.
Lonza launches TheraPRO CHO media system for therapeutic protein manufacture
Lonza has launched the TheraPRO CHO media system, a new cell-culture platform that simplifies processes and optimises productivity and protein quality when used with GS-CHO cell lines. The launch supports pharmaceutical and biotechnology companies manufacturing therapeutic proteins to further improve product quality while streamlining time to market.
Thermo Fisher Scientific launches scalable Diomni Enterprise software for molecular diagnostics
Thermo Fisher Scientific has introduced Diomni Enterprise software to address challenges with manual molecular testing workflows, with the aim of helping streamline routine diagnostics testing for standardisation and faster results.
Revvity establishes Scientific Centre of Excellence for genomic insight
Global health science solutions company Revvity has announced the establishment of a Scientific Centre of Excellence in Cambridge, UK. Focused on driving genomic insights to accelerate therapeutic discovery, Revvity’s Scientific Centre of Excellence supports the company’s commitment to expanding boundaries in pursuit of a better future for human health.
Cell therapy firm Orgenesis announces name change and additional funding for POC business
Orgenesis, a global biotech company working in cell and gene therapies (CGT) at the point of care, has announced the name change of the POC Services business from Morgenesis to Octomera, effective 30 June 2023, to reflect the growth and focus on providing advanced CGT services, facilities, and technologies.
MHRA’s new Corporate Plan focuses on patient access to innovation
A new Corporate Plan, setting out how the Medicines and Healthcare products Regulatory Agency (MHRA) plans to keep patients safe by enabling access to innovative, safe and effective medical products over the coming three years, has been published.
Microbiology Society responds to Parliamentary Inquiry on COVID-19
The Microbiology Society has welcomed the opportunity from the House of Commons Science and Technology Committee to respond to the inquiry on emerging diseases and lessons learned from COVID-19. The Society consulted with its members that were directly involved in the national response to the pandemic to co-ordinate its response.
NK:IO awarded £1.6 million to develop pioneering NK cell therapy
NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has been awarded £1.6 million in grant funding from Innovate UK’s New Cancer Therapeutics programme.
Mixed-reality training platform for healthcare sector awarded funding
UK immersive technology company FourPlus, along with collaborators Holosphere and the Cell and Gene Therapy Catapult, has been awarded funding from Innovate UK to create and test a mixed-reality training platform that enables customised training delivery for pharmaceutical companies and healthcare.
NHS expands virtual wards to paediatric patients
An expansion of virtual wards will see up to tens of thousands of children able to receive hospital-level care at home, NHS Chief Executive Amanda Pritchard has announced on the 75th anniversary of the NHS.
Novacyt and Yourgene announce merger plans
Diagnostics firm Novacyt has agreed a takeover of Yourgene, a genomic medicine company based in Manchester, in a deal worth £16.7 million.
New £14 million investment targets rare diseases
A new platform will bring together UK strengths in rare diseases research to improve diagnosis and treatment through better understanding of the disease. The UK Rare Disease Research Platform has been established with a £14 million investment over five years by the Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR).
Sphere Fluidics expands Cyto-Mine capabilities
Single cell analysis company Sphere Fluidics has announced updates to its flagship platform, Cyto-Mine, enabling it to be compliant with current Good Manufacturing Practice (cGMP) regulations enforced by the US FDA. By meeting these legally mandated, quality requirements, the company now provides a solution to increase efficiency and productivity of cell line characterisation and selection within drug manufacture workflows.
New online experience from Alpha Laboratories
Alpha Laboratories launched its new website, which has been designed to offer scientists and clinicians easier access to a wealth of information, across its laboratory and diagnostics supplies, services and solutions.
New high-capacity digital hotplates and stirrers from Torrey Pines Scientific
Torrey Pines Scientific has launched its new EchoTherm high capacity hot plates and digital stirring hot plates.
MHRA updates timeframe for CE-marked medical devices
Following the legislation introduced during May to extend the acceptance of CE-marked medical devices on the Great Britain market, the MHRA has further updated its future plans
Biotium introduces labelling kits for IgM antibodies
Biotium has announced the release of its latest product, Mix-n-Stain CF Dye IgM Antibody Labelling Kits. These kits are able to enhance the labelling process for IgM antibodies, enabling researchers to easily obtain high-performance fluorescent IgM conjugates with minimal hands-on time and no purification after labelling.
Featured Supplier
The British In Vitro Diagnostics Association represents the IVD Industry in the UK, to Government, professional bodies, the public, and at MedTech Europe. Giving support to members on regulatory issues, BIVDA also promotes the clinical and cost utility of IVDs in the provision of effective healthcare, both in acute diagnosis and in the prediction...
Upcoming Events
Digital Pathology & AI Congress: Europe
The Intercontinental London Hotel, The O2, London SE10 0TW
7-8 December
POCT Innovators: The Power to Disrupt Series
Cloth Hall Court, Leeds. UK
20 March, 2024
USCAP 113th Annual Meeting
Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024
ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases
Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024
British Society for Microbial Technology Annual Microbiology Conference
Royal Air Force Museum, Hendon, London
2 May 2024
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
